Skip to main content
. 2022 Sep 24;18:17455057221125577. doi: 10.1177/17455057221125577

Figure 4.

Figure 4.

Cardiovascular outcomes in the ARCH and FRAME studies 12-month study period.

Information in table assessed from 1. United States Food and Drug Administration (FDA) 28 ; FDA presentation: Cardiovascular Safety Assessment.